ELIGARD is the lowest priced (Wholesale Acquisition Cost/WAC) leuprolide acetate across all dosage regimens (1, 3, 4, and 6 months), which may help patients save on out-of-pocket costs*.

See package insert for full prescribing and safety information. Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post.

--Tolmar Pharmaceuticals, Inc., a fully integrated pharmaceutical company, through its affiliate, Tolmar, Inc., today announced the acquisition of all rights to JATENZO ® from Clarus Therapeutics ...

QLT Inc. <QLTI.O> <QLT.TO> said its subsidiary will pay $112.5 million to settle a patent infringement lawsuit related to its prostrate cancer drug Eligard.